BPC-157 & TB-500 & GHK-Cu Dosage Guide
Complete guide to BPC-157 & TB-500 & GHK-Cu dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
Typical protocol: BPC-157 250-500mcg daily, TB-500 2-2.5mg twice weekly, GHK-Cu 1-2mg daily or applied topically for skin applications.
Administration Method
BPC-157 and TB-500 via subcutaneous injection. GHK-Cu can be injected subcutaneously or used topically depending on the target area. Systemic and local administration may be combined.
Side Effects to Monitor
Generally well-tolerated. Possible injection site irritation, mild fatigue, or temporary skin discoloration with GHK-Cu.
Safety Considerations & Risks
Limited human data on this specific combination. Individual peptides not FDA approved. Copper peptides may not be suitable for those with copper metabolism disorders.